Cite
HARVARD Citation
Kaplan, S. et al. (2014). Efficacy and safety of fesoterodine 8 mg in subjects with overactive bladder after a suboptimal response to tolterodine ER. International journal of clinical practice. 68 (9), pp. 1065-1073. [Online].